Boston, MA -- (SBWIRE) -- 12/12/2013 -- At winstonsmallcap.com we focus on undervalued companies trading under $5. Right now the markets are surging and we are seeing an opportunity in micro-cap companies like we have never seen before. Let have a Look on: Nissan Motor Co., Ltd. (ADR)(OTCMKTS:NSANY), Idera Pharmaceuticals Inc(NASDAQ:IDRA), Novavax, Inc.(NASDAQ:NVAX), Apple Inc.(NASDAQ:AAPL)
Nissan Motor Co., Ltd. (ADR)(OTCMKTS:NSANY), opened its shares at the price of $17.50 for the day. Its closing price was $17.38 after losing -1.64% for the day. The company traded with the total volume of 426,856.00 shares, while its average trading volume remained 428,125.00 shares. The beta of NSANY stands at 1.28.
Will NSANY Get Buyers Even After The Recent Rally? Find Out Here
Idera Pharmaceuticals Inc(NASDAQ:IDRA), percentage change surged +6.64% to close at $2.73 with the total traded volume of 1.29 million shares, and average volume of 1.02 million. The 52 week range of the stock remained $0.19 - $3.12, while its day lowest price was $2.55 and it hit its day highest price at $2.82. Idera Pharmaceuticals, Inc. is a clinical-stage biotechnology company engaged in the discovery and development of novel synthetic deoxyribonucleic acid (DNA) - and ribonucleic acid (RNA) - based drug candidates.
Will IDRA Continue To Move Higher? Find Out Here
Novavax, Inc.(NASDAQ:NVAX), started its trading session with the price of $4.33 and closed at $4.06 by losing -3.10 %. NVAX’s stocks traded with total volume of 3.23 million shares, while the average trading volume remained 4.21 million shares. The beta of NVAX stands at 2.41. Day range of the stock was $4.02 -$4.34. Novavax, Inc. (Novavax) is a clinical stage biopharmaceutical company. The Company focuses on developing recombinant vaccines. The Company’s technology platform is based on recombinant vaccine technology that includes the virus-like particles (VLPs). The Company's vaccine candidates are genetically engineered three-dimensional nanostructures, which incorporate immunologically important recombinant proteins. In July 2013, Novavax acquired approximately 97.4% of shares in Isconova AB.
Will NVAX Get Buyers Even After The Recent Rally? Find Out Here
Apple Inc.(NASDAQ:AAPL) ended its day with the loss of -0.74% and closed at the price of $561.36 after opening at $567.00. Stock traded during its last trading session with the total volume of 12.85 million shares, as compared to its average volume of 10.93 million shares. Apple Inc. (Apple) designs, manufactures and markets mobile communication and media devices, personal computers, and portable digital music players, and a variety of related software, services, peripherals, networking solutions, and third-party digital content and applications.
Will AAPL Get Buyers Even After The Recent Rally? Find Out Here
Here at Winston we focus on undervalued companies trading under $5. Right now the markets are surging and we are seeing an opportunity in micro-cap companies like we have never seen before. We focus on companies that we feel are trading at a discount to the market for various reasons. Enter your email and track our performance! We are sure you won’t be disappointed.
http://winstonsmallcap.com/ and its owners, and their affiliates, directors and officers, and immediate family members, are hereafter collectively referred to as “WSC” or “we” or “us” or “our”). WSC publishes information (the “Information”) about publicly traded companies (the “Profiled Company” or the “Profiled Companies”) which has been obtained from various sources including publicly available sources on the internet. WSC does not undertake any due diligence or investigation of the Information it obtains or publishes.
Read Full Disclaimer at: http://winstonsmallcap.com/disclaimer
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)